- Editorial Note: This is a reference page, not a product review. Every statistic below is drawn from a named, publicly available source and linked directly.
Men's health has become one of the fastest-growing corners of the supplement industry — and also one of the most misunderstood. Below is a running collection of the statistics we reference most often across our reporting, organized by topic, with a direct source for every number.
Market Size: Men's Health Supplements
- The global men's health supplements market was estimated at $75.09 billion in 2024 and is projected to reach $132.13 billion by 2030, a CAGR of roughly 10% (Grand View Research).
- By product type, weight management supplements were the single largest category, holding 36.16% of market share in 2024 (Grand View Research).
- By age group, men 31–45 years old represent the largest buying segment, at 30.53% of the market in 2024 (Grand View Research).
Testosterone Boosters
- Estimates of the global testosterone booster market for 2026 range from $6.13 billion to $6.8 billion, depending on methodology, with most forecasts projecting continued growth through 2030–2035 (Research and Markets).
- Total testosterone in men declines by roughly 1% per year after age 40 on average (Harvard Health; Mayo Clinic).
- By age 70, that gradual decline can add up to roughly 30% below peak testosterone levels for the average man (Mayo Clinic).
- Despite the decline, only about 10–25% of older men actually fall below the clinical threshold for low testosterone — most remain within the normal range (Mayo Clinic).
Prostate Health (BPH)
- Up to 50% of men over age 50 experience lower urinary tract symptoms related to benign prostatic hyperplasia (BPH), rising to as much as 80% of men over 80 (NCBI/StatPearls).
- By decade: clinical BPH with moderate-to-severe symptoms affects roughly one quarter of men in their 50s, one third in their 60s, and about half of men 80 and older (NCBI).
- Histological BPH (detectable at the tissue level, whether symptomatic or not) is present in 50–60% of men in their 60s, and 80–90% of men over 70 (NCBI).
Erectile Function
- About 40% of men are affected by some degree of erectile dysfunction (ED) at age 40, with prevalence rising roughly 10 percentage points per decade after that (SingleCare).
- By age 70, an estimated 70% of men report some degree of ED, though complete ED affects a much smaller share — about 5% at age 40, rising to 15% by age 70 (SingleCare).
Sleep
- The global sleep aid and supplement market is projected in the $53–98 billion range for 2026, depending on scope, with the sleep-supplement-specific segment estimated near $9.94 billion (Grand View Research).
- Insomnia is the largest single segment of the sleep aid market, and a 2024 meta-analysis put global insomnia prevalence between 12.4% and 16.3% of adults (Grand View Research).
- In the U.S. alone, an estimated 50–70 million adults live with a diagnosed sleep disorder, most commonly insomnia (American Sleep Association, cited via Grand View Research).
Why Men Avoid the Doctor
- In a Cleveland Clinic survey, only about half of men said they get regular checkups, and 72% said they'd rather do a household chore — including cleaning the bathroom — than see a doctor (Cleveland Clinic via CBS News).
- A separate Cleveland Clinic survey found 65% of men avoid medical attention for as long as possible, and 44% don't regularly see a primary care provider at all (AARP).
- The CDC reports that women are about 33% more likely to visit the doctor than men, and are far more consistent with preventive screening (AARP).
- 41% of men said they were raised believing that complaining about health issues was a sign of weakness — a belief that tracks closely with delayed diagnosis for conditions like BPH and low testosterone (Texas Health).
Why This Matters
Taken together, these numbers tell a consistent story: the conditions driving demand in the men's health supplement market (declining testosterone, BPH, sleep disruption, erectile changes) are extremely common by midlife, yet the same population is statistically the least likely to seek professional care early. That combination — high prevalence, low proactive engagement — is a large part of why this category continues to grow faster than the broader supplement market.
This page will be updated periodically as new research and market reports are published. If you're citing a figure from this page, please link back to the original source listed alongside it.




